Progyny Rises Again as Wall Street Keeps Buying Fertility-Benefits Rebound
Progyny Inc. shares climbed 3.4% to $25.83 Thursday morning after analyst upgrades and steady demand. The company reported record Q1 revenue of $328.5 million and net income of $24.2 million, despite losing a major client last year. Progyny announced a $200 million share buyback on May 26. The firm expects 2026 revenue between $1.365 billion and $1.405 billion.